ABCL vs SQ
Abcellera Biologics Inc (ABCL) versus SQ (SQ) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
SQ (SQ) common stock.
Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.
SQ does not have a complete income-statement cache yet.
ABCL currently screens at market cap $1.12B.
Not investment advice. Open the ABCL and SQ stock pages for the full models.
Not investment advice.